...
首页> 外文期刊>癌と化学療法 >The incidence and management of bone metastasis from breast cancer
【24h】

The incidence and management of bone metastasis from breast cancer

机译:来自乳腺癌骨转移的发病率和管理

获取原文
获取原文并翻译 | 示例

摘要

Mammary cancer is one of the solid malignancies, which easily metastasizes to bone. The frequency of bone metastases of breast cancer has been reported to be 65-75% of all breast cancer patients, and, in autopsy example at Shikoku Cancer Center, metastasis was recognized to be 74.7%. There are many symptomatic signs of bone metastases, but hypercalcemia needs to be treated immediately. Hypercalcemia might be diagnosed precisely because a lethal symptom appears. For diagnosis, bone scintigram, simple X-rays, MRI, and CT scan were effective. Radiotherapy, surgery, chemotherapy, and hormonal treatments were useful to improve the symptoms from bone metastasis; in addition, bisphosphonates demonstrated a synergistic effect with chemoendocrine treatments. Bisphosphonates also reduced the incidence of symptom-related events in patients with bone metastasis.
机译:乳腺癌是固体恶性肿瘤之一,其容易转移到骨骼。 据报道,乳腺癌的骨转移频率为所有乳腺癌患者的65-75%,并且在颅内癌症中心的尸检实例中,转移被认为是74.7%。 骨转移有许多症状迹象,但需要立即治疗高钙血症。 高钙血症可能被准确地诊断出,因为出现了致命的症状。 对于诊断,骨闪烁,简单的X射线,MRI和CT扫描是有效的。 放射疗法,手术,化学疗法和荷尔蒙治疗可用于改善骨转移的症状; 此外,双膦酸盐表明了与化学内分泌处理的协同作用。 双膦酸盐还降低了骨转移患者症状相关事件的发生率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号